YBX1 and cancer: Accordingly, YB-1 overexpression predicted poor prognosis of patients in multiple cancers including GC [27], and the upregulation of YB-1 in either GC cells or cancer vascular endothelial cells, respectively, indicated advanced cancer stage and more active angiogenesis based on the analysis of GC specimens [17, 18].